Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 4:56 pm Purchase |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Stonepine Capital Management, LLC | 11 0.400% |
11 (New Position) |
Filing History |
| 2021-02-12 4:54 pm Sale |
2020-12-31 | 13G | Affimed N.V. AFMD |
Stonepine Capital Management, LLC | 21,934 0.200% |
-379,082 (-94.53%) |
Filing History |
| 2021-02-12 4:48 pm Sale |
2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
Stonepine Capital Management, LLC | 808,431 2.800% |
-1,432,808 (-63.93%) |
Filing History |
| 2021-02-12 4:43 pm Purchase |
2020-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Stonepine Capital Management, LLC | 2,603,480 9.990% |
462,201 (+21.59%) |
Filing History |
| 2021-02-12 4:37 pm Purchase |
2020-12-31 | 13G | Amryt Pharma plc AMYT |
Stonepine Capital Management, LLC | 11,082,415 6.200% |
11,082,415 (New Position) |
Filing History |
| 2021-02-12 4:26 pm Purchase |
2020-12-31 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 8,148,420 9.990% |
4,534,820 (+125.49%) |
Filing History |
| 2021-02-05 6:39 pm Purchase |
2021-01-28 | 13G | Applied Genetic Technologies Corporation AGTC |
Stonepine Capital Management, LLC | 2,273,876 5.200% |
2,273,876 (New Position) |
Filing History |
| 2020-12-23 5:12 pm Purchase |
2020-12-17 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 1,536,953 7.700% |
1,536,953 (New Position) |
Filing History |
| 2020-12-16 6:02 pm Purchase |
2020-12-11 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 26,666,680 7.700% |
26,666,680 (New Position) |
Filing History |
| 2020-09-11 4:34 pm Purchase |
2020-09-03 | 13G | Interpace Biosciences, Inc. IDXG |
Stonepine Capital Management, LLC | 277,277 6.900% |
169,517 (+157.31%) |
Filing History |
| 2020-08-05 4:09 pm Purchase |
2020-03-03 | 13G | Catalyst Biosciences, Inc. CBIO |
Stonepine Capital Management, LLC | 263,481 6.000% |
263,481 (New Position) |
Filing History |